Navigation Links
Implantable devices to be powered by organosilicon compounds in the future

Medical technology has advanced so much to the extent of replacing lost organs or improving function of existing ones using artificial implants. These implantable devices are becoming commonplace today by serving as a good // alternative to the conventional treatment.

Such effective utilization would not have been possible without the availability of lithium batteries that supply power, thereby ensuring functionality of these tiny, yet useful devices. Designed to be extraordinarily reliable and work continuously for years, the batteries that power implantables are indispensable in everything from pacemakers to the electronic stimulators that help restore function in the brains of Parkinson's patients.

However, lithium batteries don't last forever and new surgery to maintain many devices seeded into the body is required. It is both a physical and financial strain for the patient. In an attempt to ensure superior performance, scientists are now working on silicon-based compounds that are used in the treatment of nervous and other disorders. The unique rechargeable ability of the new generation battery confers twice as longer lifetime than the ones currently used.

This offers a new ray of hope in medical treatment as these new generation electrical devices could be used to stimulate the nervous system, treat incontinence and overcome muscular impairment.

Central to that ability and vision, is emerging a new lithium battery technology, capable of making batteries smaller, last longer and, soon, accept a charge from outside the body without the need for surgery. "It turns out the organosilicon compounds (compounds made of silicon and other natural materials) are really good for improving lithium battery technology," says West, one instrumental behind this significant development. The new battery technology powers a "microstimulater" not much larger than a pencil lead and can be injected near target nerves to help overcome t he faulty nervous system wiring at the heart of Parkinson's, epilepsy and incontinence.

They're very flexible, stable, nonflammable, non-toxic and do not pose a threat to the environment, according to the researchers. The average expected life span of these batteries is expected to be over 12 years. Furthermore, it makes use of Silicon, one of the Earth's most abundant elements.

In addition to implantable devices for medicine, lithium batteries are used in scores of applications, from spacecraft to iPods. We will have to watch and wait for some time before the power of these batteries can be exploited to the maximum.
'"/>




Related medicine news :

1. Implantable Contact Lens Found Safe and Effective
2. New Implantable Device That Can Keep The Heart Ticking
3. Making MRIs Safe for Patients With Implantable Heart Devices
4. Combination therapy for patients treated with Implantable Cardioverter Defibrillator
5. New Implantable Cardioverter Defibrillators to avoid unnecessary shocks
6. First Implantable artificial heart gets FDA’s approva
7. Futuristic devices are here to take care of dental problems
8. Cheap Indian devices sought to treat sleep disorder
9. Bionic muscles developed by scientists powered by alcohol and hydrogen
10. Patients Empowered to Force for Better Services
11. China Introduces Solar-powered Baths
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... ... April 25, 2017 , ... Amendia, Inc., designer, ... its strategic partnership with and platinum sponsorship of Global Spine Outreach (“GSO”), a ... effective management of complex spine deformity cases, particularly in children. , GSO’s focus ...
(Date:4/24/2017)... Lake City, UT (PRWEB) , ... April 24, 2017 , ... ... their efforts to encourage sustainability, innovate new strategies to reduce waste, and support renewable ... herbal remedy provider. They look to nature to find solutions for health issues, and ...
(Date:4/24/2017)... , ... April 24, 2017 , ... The California Dental ... in charitable dental services to 1,961 people during the April 22-23 event at the ... charge to Californians who experience barriers to care, CDA Cares educates the public and ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... seeking public support to bring their novel lifesaving device for the everyday use ... with medical-grade sensors, specially designed to read a child’s vital signs, and detect ...
(Date:4/24/2017)... CA (PRWEB) , ... April 24, 2017 , ... ... brain tumors are expected to be diagnosed globally; approximately 25,000 of them will ... are anticipating greater use of this type of healthcare model in the diagnosis ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  AbbVie (NYSE: ... 99 percent (n=145/146) of chronic hepatitis C virus ... 5 or 6 and compensated cirrhosis (Child-Pugh A) ... (SVR 12 ) with its investigational, pan-genotypic regimen ... rates were seen following 12 weeks of G/P ...
(Date:4/20/2017)... NeuroVive Pharmaceutical AB (Nasdaq Stockholm: ... preclinical results demonstrating anti-fibrotic effects with NV556, ... (NASH), in an additional well-validated experimental NASH ... previously shown similar anti-fibrotic effects in the ... present novel data demonstrating anti-fibrotic effects of ...
(Date:4/19/2017)... Cardiology devices segment is anticipated to reach the ... Cardiology Devices segment is likely to create absolute $ opportunity ... over 2017. By the end of 2027, Cardiology Devices segment ... 700 Mn, expanding at a CAGR of 18.4% over the ... Asia Pacific reprocessed medical devices market in terms ...
Breaking Medicine Technology: